Author:
Vellayappan Balamurugan A.,Venur Vyshak A.,Mayr Nina A.,Hofstetter Christoph P.,Lo Simon S.,Amin Anubhav G.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical),Surgery
Reference8 articles.
1. Initial management of noncastrate advanced, recurrent, or metastatic prostate cancer: ASCO guideline update;Virgo;J Clin Oncol.,2021
2. Dose response and fractionation sensitivity of prostate cancer after external beam radiation therapy: a meta-analysis of randomized trials;Vogelius;Int J Radiat Oncol Biol Phys.,2018
3. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial;Sahgal;Lancet Oncol.,2021
4. Spine stereotactic body radiotherapy for prostate cancer metastases and the impact of hormone sensitivity status on local control;Abugharib;Neurosurgery.,2022
5. Outcomes of Patients with spinal metastases from prostate cancer treated with conventionally-fractionated external beam radiation therapy;Lee;Global Spine J.